{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:57Z","timestamp":1792784337844,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German National Genome Research Network","award":["01GS08136-4"],"award-info":[{"award-number":["01GS08136-4"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["HO 2402\/6-1"],"award-info":[{"award-number":["HO 2402\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.neurobiolaging.2014.01.027","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T05:16:00Z","timestamp":1390972560000},"page":"1700-1711","source":"Crossref","is-referenced-by-count":61,"title":["Trifluoperazine rescues human dopaminergic cells from wild-type \u03b1-synuclein-induced toxicity"],"prefix":"10.1016","volume":"35","author":[{"given":"Matthias","family":"H\u00f6llerhage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0545-3546","authenticated-orcid":false,"given":"Joachim N.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Dolga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Culmsee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-9795","authenticated-orcid":false,"given":"Bastian","family":"Hengerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib1","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/path.2694","article-title":"Autophagy: assays and artifacts","volume":"221","author":"Barth","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2202-11-41","article-title":"Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells","volume":"11","author":"Bisaglia","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(11)70227-7","article-title":"Modelling of Parkinson's disease in mice","volume":"10","author":"Chesselet","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib7","doi-asserted-by":"crossref","first-page":"33380","DOI":"10.1074\/jbc.M111.268409","article-title":"Enhanced autophagy from chronic toxicity of iron and mutant A53T \u03b1-synuclein: implications for neuronal cell death in Parkinson disease","volume":"286","author":"Chew","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib8","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy","volume":"286","author":"Choubey","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2010.01.053","article-title":"Autophagy protects the rotenone-induced cell death in alpha-synuclein overexpressing SH-SY5Y cells","volume":"472","author":"Dadakhujaev","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib12","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib13","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in\u00a0vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of \u03b1-synuclein","volume":"31","author":"Ebrahimi-Fakhari","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib15","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"\u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.500","article-title":"Chemical modulators of autophagy as biological probes and potential therapeutics","volume":"7","author":"Fleming","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib18","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","article-title":"Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of \u03b1-synuclein in Parkinson's disease models","volume":"22","author":"Hebron","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease","volume":"364","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4161\/auto.19371","article-title":"Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway","volume":"8","author":"Klucken","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/NEN.0b013e31818c3618","article-title":"Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells","volume":"67","author":"Ko","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib24","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1074\/jbc.M709634200","article-title":"Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers","volume":"283","author":"Kostka","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib27","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.11.068","article-title":"Parkinson's disease involves autophagy and abnormal distribution of cathepsin L","volume":"489","author":"Li","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.phrs.2011.01.004","article-title":"Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism","volume":"63","author":"Liu","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib30","doi-asserted-by":"crossref","first-page":"38884","DOI":"10.1074\/jbc.M205518200","article-title":"Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line","volume":"277","author":"Lotharius","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib31","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1523\/JNEUROSCI.1746-05.2005","article-title":"Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway","volume":"25","author":"Lotharius","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib32","doi-asserted-by":"crossref","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","article-title":"The role of autophagy in Parkinson's disease","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib35","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib36","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A\u00a0novel \u03b1-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2008.02.021","article-title":"Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells","volume":"435","author":"Qian","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddl036","article-title":"Rapamycin pre-treatment protects against apoptosis","volume":"15","author":"Ravikumar","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/jnnp-2011-301205","article-title":"Molecular pathogenesis of Parkinson's disease: update","volume":"83","author":"Saiki","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib43","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.4161\/auto.21275","article-title":"SNCA (\u03b1-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy","volume":"8","author":"Sampaio-Marques","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/auto.5269","article-title":"Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila","volume":"4","author":"Simonsen","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib46","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib48","article-title":"Latrepirdine stimulates autophagy and reduces accumulation of \u03b1-synuclein in cells and in mouse brain","author":"Steele","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib49","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","volume":"21","author":"Stefanis","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib50","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/cdd.2011.53","article-title":"A\u00a0deadly spread: cellular mechanisms of \u03b1-synuclein transfer","volume":"18","author":"Steiner","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib51","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00401-011-0926-8","article-title":"Aggregation of \u03b1Synuclein promotes progressive in\u00a0vivo neurotoxicity in adult rat dopaminergic neurons","volume":"123","author":"Taschenberger","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib52","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1073\/pnas.1004498107","article-title":"A\u00a0small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model","volume":"107","author":"Tsvetkov","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib53","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cbic.201100569","article-title":"Autoproteolytic fragments are intermediates in the oligomerization\/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometry","volume":"12","author":"Vlad","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib54","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Vogiatzi","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib55","doi-asserted-by":"crossref","first-page":"e38545","DOI":"10.1371\/journal.pone.0038545","article-title":"The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease","volume":"7","author":"Wan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib56","doi-asserted-by":"crossref","first-page":"17797","DOI":"10.1073\/pnas.1113260108","article-title":"A\u00a0soluble \u03b1-synuclein construct forms a dynamic tetramer","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib57","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib58","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In\u00a0vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"\u03b1-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4161\/auto.7.4.14393","article-title":"The Parkinson disease protein \u03b1-synuclein inhibits autophagy","volume":"7","author":"Winslow","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncb2217","article-title":"Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease","volume":"13","author":"Wong","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2014.01.027_bib62","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","article-title":"Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy","volume":"4","author":"Xilouri","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib65","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","article-title":"Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein","volume":"175","author":"Yu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib66","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib67","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.01.027_bib68","doi-asserted-by":"crossref","first-page":"e36377","DOI":"10.1371\/journal.pone.0036377","article-title":"Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801400044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745801400044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T23:40:09Z","timestamp":1565134809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745801400044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S019745801400044X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.027","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}